Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R, Bañares R, Castells L, Jimenez De Anta MT, Arroyo V, Rodés J.

Gastroenterology. 1996 Oct;111(4):1011-7.

PMID:
8831596
2.

Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.

Taşkiran B, Colakoğlu O, Sözmen B, Unsal B, Aslan SL, Buyraç Z.

Turk J Gastroenterol. 2004 Mar;15(1):34-8.

3.

Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.

Tuncer I, Topcu N, Durmus A, Turkdogan MK.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1426-30.

PMID:
14571754
4.

Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.

Terg R, Cobas S, Fassio E, Landeira G, Ríos B, Vasen W, Abecasis R, Ríos H, Guevara M.

J Hepatol. 2000 Oct;33(4):564-9.

PMID:
11059861
5.

Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.

Kaymakoglu S, Eraksoy H, Okten A, Demir K, Calangu S, Cakaloglu Y, Boztas G, Besisik F.

Eur J Gastroenterol Hepatol. 1997 Jan;9(1):71-6.

PMID:
9031903
6.

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

Ricart E, Soriano G, Novella MT, Ortiz J, Sàbat M, Kolle L, Sola-Vera J, Miñana J, Dedéu JM, Gómez C, Barrio JL, Guarner C.

J Hepatol. 2000 Apr;32(4):596-602.

PMID:
10782908
7.

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.

Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Ginès A, Ginès P, Rodés J.

Hepatology. 1993 Feb;17(2):251-7.

PMID:
8428722
8.

Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.

Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.

Am J Gastroenterol. 1998 Dec;93(12):2457-62.

PMID:
9860409
9.

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M.

Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285.

PMID:
17030175
10.

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.

Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.

Cancer. 1999 Jan 1;85(1):213-9.

PMID:
9921995
11.

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.

Rimola A, Salmerón JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Solá R, Vargas V, et al.

Hepatology. 1995 Mar;21(3):674-9.

PMID:
7875666
12.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginès P, Rodés J.

N Engl J Med. 1999 Aug 5;341(6):403-9.

13.

[Stage-oriented antibiotic therapy of peritonitis. Prospective study].

Winkeltau GJ, Töns C, Bertram P, Schumpelick V.

Langenbecks Arch Chir. 1997;382(4 Suppl 1):S22-5. German.

PMID:
9333703
14.

[A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis].

Li HW, Zhao P, Wang HF, Ji W, He WP, Du N, Xia J.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Jun;18(2):179-80. Chinese.

PMID:
15340512
15.

The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Ljubicic N, Spajic D, Vrkljan MM, Altabas V, Doko M, Zovak M, Gacina P, Mihatov S.

Hepatogastroenterology. 2000 Sep-Oct;47(35):1360-3.

PMID:
11100352
16.

Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.

Rimola A, Navasa M, Arroyo V.

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):141-5. Review.

PMID:
7587029
17.

Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short-term prognosis.

Mesquita MA, Balbino EP, Albuquerque RS, Carmona CA, Okubo BT, Lorena SL, Montes CG, Soares EC.

Hepatogastroenterology. 1997 Sep-Oct;44(17):1276-80.

PMID:
9356840
18.

Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.

Ariza J, Xiol X, Esteve M, Fernández Bañeres F, Liñares J, Alonso T, Gudiol F.

Hepatology. 1991 Jul;14(1):91-8.

PMID:
2066075
19.

Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.

Fernández J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jiménez W, Bosch J, Arroyo V.

J Hepatol. 2004 Sep;41(3):384-90.

PMID:
15336440
20.

Clinical and laboratory features of spontaneous bacterial peritonitis.

Filik L, Unal S.

East Afr Med J. 2004 Sep;81(9):474-9.

PMID:
15626058

Supplemental Content

Support Center